Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $439.00 by Morgan Stanley
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) has been assigned a $439.00 target price by equities research analysts at Morgan Stanley in a research report...
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, August 14th....
Royal Bank Of Canada Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price lowered by analysts at Royal Bank Of Canada from $430.00 to $405.00 in a...
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $455.00 by Stifel Nicolaus
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) has been given a $455.00 price target by equities research analysts at Stifel Nicolaus in a note issued...
Traders Buy High Volume of Call Options on Unity Software (NYSE:U)
Unity Software Inc. (NYSE:U – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors purchased 95,545 call options...
Stock Traders Purchase High Volume of C3.ai Call Options (NYSE:AI)
C3.ai, Inc. (NYSE:AI – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors bought 182,940 call options on...